Grace Therapeutics, Inc. (GRCE) financial statements and ratios from SEC XBRL: revenue $685000.00 (TTM), net margin -1137.7%, revenue growth -3.7% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $685000.00 |
| Net Margin | -1137.7% |
| Revenue Growth (YoY) | -3.7% |
| EPS Growth (YoY) | -40.5% |
| Price / Book | 0.96 |
| Price / Sales | 67.27 |
| Altman Z-Score | 2.73 (grey) |
| Sector P/E (Healthcare) | 21.7 |
GRCE overview · GRCE earnings · GRCE KPIs · GRCE investor relations · GRCE ownership · GRCE peers · GRCE filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.